The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

Cryptorchidism concordance in monozygotic and dizygotic twin brothers, full brothers, and half-brothers Morten Søndergaard Jensen, M.D., Gunnar Toft,

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN,C) Michael W. Pankhurst,

Age at menarche: a predictor of diminished ovarian function?

Christine Jablonski, M. D. , Marco Alifano, M. D

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

The normal variabilities of the menstrual cycle

Bjørn Bay, M. D. , Erik Lykke Mortensen, M. Sc

1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for.

Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast.

Michael M. Alper, M.D. Fertility and Sterility

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Ramifications of adolescent menstrual cycles ≥42 days in young adults

Patient-tailored ovarian stimulation for in vitro fertilization

Fertility preservation and refreezing of transplanted ovarian tissue—a potential new way of managing patients with low risk of malignant cell recurrence

Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause Linlin Cui, M.D., Ph.D., Yingying.

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women Ellen W. Freeman, Ph.D.,

Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Isabelle.

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

Biomarkers of ovarian response: current and future applications

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.

Mikkel Rosendahl, M. D. , Claus Yding Andersen, D. M. Sc

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Prospective evaluation of luteal phase length and natural fertility

Oocyte cryopreservation

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH) P. Barriere, T. Freour, D. Masson,

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.

Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation Jacques Donnez,

Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study Li Wei, Ph.D., Thomas MacDonald, M.D.,

Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization Thomas Brodin,

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review Carlo Alviggi, M.D., Ph.D., Alessandro Conforti,

Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B Matti Hero, M.D., Ph.D., Johanna Tommiska,

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Kirstine Kirkegaard, M. D. , Johnny Juhl Hindkjaer, M. Sc

A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

Effectiveness of highly purified human menopausal gonadotropin vs

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.

Fertility and Sterility: an evaluation

Paolo Moghetti, M.D. Fertility and Sterility

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Current evaluation of amenorrhea

True ovarian volume is underestimated by two-dimensional transvaginal ultrasound measurement Mikkel Rosendahl, M.D., Erik Ernst, Ph.D., Per Emil Rasmussen,

Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility H.-H.

Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Early menopause in mothers of children with Down syndrome?

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Maternal serum screening markers and nuchal translucency measurements in in vitro fertilization pregnancies: a systematic review Andrea Lanes, M.Sc.,

Presentation transcript:

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women Susanne Lund Kristensen, M.D., Cecilia Høst Ramlau-Hansen, Ph.D., Claus Yding Andersen, D.M.Sc., Erik Ernst, Ph.D., Sjurdur Frodi Olsen, Ph.D., Jens Peter Bonde, D.M.Sc., Anne Vested, M.Sc., Gunnar Toft, Ph.D. Fertility and Sterility Volume 97, Issue 3, Pages 779-785 (March 2012) DOI: 10.1016/j.fertnstert.2011.12.017 Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Scatter plots depicting the unadjusted relationships between serum antimüllerian hormone (AMH) and number of follicles, total T, free androgen index, and cycle length. The observations are divided into two groups depending on use of hormonal contraceptives. Fertility and Sterility 2012 97, 779-785DOI: (10.1016/j.fertnstert.2011.12.017) Copyright © 2012 American Society for Reproductive Medicine Terms and Conditions